AIRS Medical has been named a Quarterfinalist in the 2026 Digital Health & AI Awards in the Best in Class Track – Healthy Lifespan, Longevity & Prevention category.
The Digital Health & AI Awards, presented by the Digital Health Hub Foundation, recognize companies and innovations helping shape the future of healthcare across digital health, artificial intelligence and healthcare technology.
The recognition reflects AIRS Medical’s focus on consistent quantitative MRI and more confident longitudinal brain assessment through SwiftSight.
Consistent Quantitative MRI You Can Trust
SwiftSight is AIRS Medical’s quantitative brain imaging solution designed to reduce measurement variability and enable more confident longitudinal brain assessment. By delivering consistent quantitative measurements across scanners, field strengths and imaging environments, SwiftSight helps clinicians determine whether a measured change reflects the patient — or the scanner.
“Longevity is about understanding how health changes over time, and that requires measurements you can trust,” said Jina Park, Chief Strategy Officer at AIRS Medical. “With SwiftSight, our goal is to make quantitative MRI consistent across scanners so we can measure the patient — not the scanner. We’re proud to have that vision recognized in the Healthy Lifespan, Longevity & Prevention category.”
The Road to HLTH 2026
Quarterfinalists advance to the next stage of judging, with Finalists scheduled to be announced on October 12, 2026.
The 2026 Digital Health & AI Awards will culminate at the Grand Finale on November 16 at HLTH in Las Vegas, where the Rising Star and Best in Class winners will be announced.
About the Digital Health & AI Awards
The Digital Health & AI Awards are presented by the Digital Health Hub Foundation, a nonprofit organization focused on identifying, recognizing and elevating the companies and innovations shaping the future of health.
Founded in 2017 on the UCSF campus in San Francisco, the Foundation brings together healthcare innovators, clinicians, researchers, investors, technology leaders and other members of the healthcare ecosystem.
About AIRS Medical
AIRS Medical is a global AI medical imaging company transforming MRI through deep learning. Its solutions, SwiftMR® and SwiftSight®, are deployed at leading health systems and imaging networks worldwide. SwiftMR® is FDA-cleared, CE-marked under MDR, and approved by Korea’s MFDS, Japan’s PMDA, and other regulatory authorities across 40+ countries. Learn more at airsmed.com.
Media Contact
Cynthia Ruffino
Vice President, Marketing
media@airsmed.com